Abstract:Natural bisindole alkaloids such as Hyrtinadine A and Alocasin A, which are known to exhibit diverse bioactivities, provide promising chemical scaffolds for drug development. By optimizing the Masuda borylation–Suzuki coupling sequence, a library of various natural product-derived and non-natural (di)azine-bridged bisindoles was created. While unsubstituted bisindoles were devoid of antibacterial activity, 5,5′-chloro derivatives were highly active against methicillin-resistant Staphylococcus aureus (MRSA) and further Gram-positive pathogens at minimal inhibitory concentrations ranging from 0.20 to 0.78 μM. These compounds showed strong bactericidal killing effects but only moderate cytotoxicity against human cell lines. Furthermore, the two front-runner compounds 4j and 4n exhibited potent in vivo efficacy against MRSA in a mouse wound infection model. Although structurally related bisindoles were reported to specifically target pyruvate kinase in MRSA, antibacterial activity of 4j and 4n is independent of pyruvate kinase. Rather, these compounds lead to bacterial membrane permeabilization and cellular efflux of low-molecular-weight molecules.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00826?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00826</a>.MICs of compounds 4 against all tested bacteria strains (Table S1); cytotoxicity data of compounds 4j, 4n, and 4q against the human cell lines HEK293, HepG2, and CLS-54 (Table S2); SNPs present in MRSA resistant mutants (Table S3); MICs of compounds of different classes against MRSA resistant mutants and wild-type (Table S4); dose–response curve of compound 4r against MRSA (Figure S1); solubility assessment of compounds 4c, 4d, 4j, 4n, and 4r (Figure S2); absorption maxima of compounds 4c, 4d, 4j, 4n, and 4r (Figure S3); hemolytic activity of 4j and 4n on sheep red blood cells (Figure S4); stability evaluation of compound 4c (Figure S5); dose–response curves for 4d, 4n, 4q, and 4s against MRSA LAC WT and LAC Δpyk::ErmR in minimal medium M9 (Figure S6); studies describing optimization of reaction conditions (Scheme S1 and Table S5); analytical data of compounds 1a, 4a–4f, 4j, 4l–4n, 4p–4s, 4u, and 4v including 1H and 13C NMR spectra (Figures S7–S40) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Nosiheptide Analogues As Potential Antibacterial Agents Via Dehydroalanine Region Modifications: Semi-synthesis, Antimicrobial Activity and Molecular Docking Study.

Insights into the Substrate Tolerance of Enzymes Involved in the Nosiheptide Biosynthesis Pathway Based on Indolic Acid Moiety

Mutational Biosynthesis to Generate Novel Analogs of Nosiheptide Featuring a Fluorinated Indolic Acid Moiety

Mutasynthesis Generates Antibacterial Benzothiophenic-Containing Nosiheptide Analogues

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Synthesis and antibacterial activity of novel icariin derivatives.

Design, synthesis, and evaluation of N1,N3-dialkyldioxonaphthoimidazoliums as antibacterial agents against methicillin-resistant Staphylococcus aureus

Nosiheptide Biosynthesis Featuring A Unique Indole Side Ring Formation On The Characteristic Thiopeptide Framework

Mutagenesis of Precursor Peptide for the Generation of Nosiheptide Analogues

Synthesis of Novel N-Substituted β-Amino Acid Derivatives Bearing 2-Hydroxyphenyl Moieties as Promising Antimicrobial Candidates Targeting Multidrug-Resistant Gram-Positive Pathogens

Design, Synthesis and Biological Evaluation of 3-(4-halophenyl)-3-oxopropanal and Their Derivatives As Novel Antibacterial Agents

Novel Sulfonylurea Derivatives as Potential Antimicrobial Agents: Chemical Synthesis, Biological Evaluation, and Computational Study

Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial In Vitro and In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus

Design of a chimeric glycosyltransferase OleD for the site-specific O-monoglycosylation of 3-hydroxypyridine in nosiheptide

<i>N</i>-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification

An Improved Antibacterial Activity of Cephalosporin Analogues by Introducing Sulfamoylamino Group

Development of Aromatic-Linked Diamino Acid Antimicrobial Peptide Mimics with Low Hemolytic Toxicity and Excellent Activity Against Methicillin-Resistant Staphylococcus Aureus (MRSA)

Using peptide substrate analogs to characterize a radical intermediate in NosN catalysis

Exploring the potential of bis(thiazol-5-yl)phenylmethane derivatives as novel candidates against genetically defined multidrug-resistant Staphylococcus aureus